Late-Stage Venture Continues To Dominate Medtech Financing
This article was originally published in Start Up
Device start-ups raised $1.7 billion in 2013, and approximately 75% of the total was from Series C or later rounds, a sign that investors are still more comfortable making investments in more advanced companies.
You may also be interested in...
The field of neuromodulation has produced numerous start-ups and a decent amount of fundraising activity over the past six years, but exits are scarce.
A new analysis of medtech PIPE deals in Informa’s Strategic Transactions and PlacementTracker shows a rebound in transaction and dollar volume.
The last five years have been brutal ones for medical device VCs and entrepreneurs, yet there’s still cause for hope. In a series of interviews, we asked venture capitalists, entrepreneurs, and executives: what gives you hope and what makes you optimistic about the future of medtech?